Advisory Board
The board includes members from a range of life sciences companies and other academic institutions who work closely with WPI leadership to assess the university’s current programs and direct future life sciences initiatives.
Craig C. Mello Ph.D. (Chair)
Blais Professor of Molecular Medicine
Howard Hughes Medical Institute
University of Massachusetts Medical School
Program in Molecular Medicine
William C. Alexander ’81
Sr. Director/Team Leader
Global Contract Manufacturing
Pfizer, Inc.
Marni Hall Hallissey ’97, PhD, MPH
Director, Regulatory Science Staff
Office of Surveillance & Epidemiology, CDER, FDA
Peter C. Isakson, Ph.D.
Director, MassBio Board
Deborah Kochevar
Dean
Tufts Cummings School Veterinary Medicine
David G. LaPré ’73
VP Global Operations
Roche Diagnostics
Morey Kraus ’91
Chief Scientific Officer
PerkinElmer Life and Analytical Sciences, Inc.
Dr. Bruce D. Minsky ’77
Professor and Director, Clinical Research
Department of Radiation Oncology
The University of Texas MD Anderson Cancer Center
James T. Orcutt '79
President and Chief Executive Officer
New Brunswick Scientific Co.
Kevin O’Sullivan
President and CEO
Massachusetts Biomedical Initiatives
Catherine Prescott
Founder and Director, Biolatris Ltd, UK
Biolatris Ltd
St John's Innovation Centre
Richard Resnick ’98
Chief Executive Officer
GenomeQuest, Inc.
Last modified: October 26, 2012 10:49:01